SOURCE: HASCO Medical, Inc.

HASCO Medical, Inc.

May 29, 2014 08:31 ET

HASCO Medical Engages Liolios Group to Lead New Investor Relations Campaign

ADDISON, TX--(Marketwired - May 29, 2014) - HASCO Medical, Inc. (OTCQB: HASC), a leading provider of handicap-accessible vans, parts and service, has engaged Liolios Group to lead its new strategic investor relations and financial communications campaign.

"Over the last year, HASCO Medical has realized a number of major milestones, including three key acquisitions and the opening of a new Ride-Away® Commercial Taxi location in New York City to address the tremendous opportunity supported by new rules that require 7,500 yellow taxis to be wheelchair-accessible by 2020," said Shane Jorgenson, HASCO Medical's chief financial officer. "We have received a $2.5 million order for 80 wheelchair accessible cabs for use in the city, and recently engaged Swearingen Realty Group to help us with our expansion plans, which includes possible new locations before the end of the year.

"In light of this progress and positive momentum, we believe our shareholders would benefit from a team of experienced investor relations professionals that would help us strengthen communications with investors, navigate the capital markets and increase awareness of our story in the financial community," continued Jorgenson. "Liolios Group brings to HASCO a proven track record of helping growth companies like ours enhance shareholder value by delivering the right message to the right audience, and building high-quality, long-term relationships in the investment community."

Liolios Group will work closely with HASCO management to develop and deploy a new capital markets strategy, which will include focused messaging and corporate positioning, strategic advisory, and introductions to investors and key influencers. This will include scheduling road shows and financial conferences for management over the next several months.

For additional information about HASCO Medical, contact Liolios Group at (949) 574-3860 or email HASC@liolios.com.

About Liolios Group
Liolios Group, Inc. is a highly selective and comprehensive investor relations firm specializing in small-cap companies. The firm aims to deliver superior performance in corporate messaging and positioning, investor awareness, analyst and financial press coverage, and capital attraction. Founded in 1999, Liolios Group executives have extensive experience in finance and investments, and represent clients in a wide range of industries, including technology, digital media, consumer/internet retail, healthcare/life sciences, natural resources and business services. For more information about Liolios Group, please visit www.liolios.com.

About HASCO Medical, Inc.
HASCO Medical is a leading provider of handicap accessible vans, parts, and service that dramatically improve the quality of living of its customers. The company operates 19 locations from Maine to Florida, as well as provides medical equipment and supplies in Florida. The company's mobility brands include Ride-Away (www.Ride-Away.com), Auto Mobility Sales (www.automobilitysales.com) Mobility Freedom (www.MobilityFreedom.com) and Wheelchair Vans of America (www.wcvans.com). It provides durable medical equipment side through its Certified Medical subsidiary located in Ocala, Florida. To learn more, go to www.hascomed.com.

Cautionary Note Regarding Forward-Looking Statements
This press release may contain forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. In some cases you can identify those so-called "forward looking statements" by words such as "may," "will," "should," "expects," "plans," "targets," "believes," "anticipates," "estimates," "predicts," "potential," or "continue" or the negative of those words and other comparable words. These forward looking statements are subject to risks and uncertainties, product tests, commercialization risks, availability of financing and results of financing efforts that could cause actual results to differ materially from historical results or those anticipated. Further information regarding these and other risks is described from time to time in the Company's filings with the SEC, which are available on its website at: http://www.sec.gov. We assume no obligation to update or alter our forward-looking statements made in this release or in any periodic report filed by us under the Securities Exchange Act of 1934 or any other document, whether as a result of new information, future events or otherwise, except as otherwise required by applicable federal securities laws.

Contact Information

  • Company Contact:
    HASCO Medical, Inc.
    214-302-0930
    Email Contact

    Investor Relations Contacts:
    Liolios Group, Inc.
    Ron Both, Senior Managing Director
    949-574-3860
    Email Contact